SEC Tracker
Get the app

Lunai Bioworks LNAI

Lunai Bioworks delisted from Nasdaq

Item 3.01 Listing standards notice, Item 5.02 Executive or director change, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Received Nasdaq delisting notice due to stockholders deficit of $9,024,946
  2. Board approved voluntary withdrawal from Nasdaq listing
  3. No intention to request hearing or arrange OTC trading
  4. Audit and Compensation Committees now non-compliant

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Lunai Bioworks files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Dare Bioscience DARE public float $21M, Jun 30, 2025
  2. Imunon IMNN public float $21M, Jun 30, 2025
  3. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  4. Fibrogen FGEN public float $21M, Jun 30, 2025
  5. Aptose Biosciences APTOF public float $22M, Jun 28, 2025